1150617-54-1 Usage
General Description
6-Bromo-1H-pyrazolo[4,3-b]pyridine is an organic chemical compound with the molecular formula C7H4BrN3. It is a heterocyclic compound that contains a pyrazole ring fused to a pyridine ring. 6-Bromo-1H-pyrazolo[4,3-b]pyridine is used as a building block in the synthesis of pharmaceuticals and other organic compounds. It is known for its potential biological activities and has been studied for its potential use in the development of new drugs. Additionally, it can also be used as a reagent in organic chemical reactions to introduce the pyrazolo[4,3-b]pyridine moiety into various molecules. Overall, 6-Bromo-1H-pyrazolo[4,3-b]pyridine is a versatile compound with potential applications in medicinal chemistry and organic synthesis.
Check Digit Verification of cas no
The CAS Registry Mumber 1150617-54-1 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,5,0,6,1 and 7 respectively; the second part has 2 digits, 5 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 1150617-54:
(9*1)+(8*1)+(7*5)+(6*0)+(5*6)+(4*1)+(3*7)+(2*5)+(1*4)=121
121 % 10 = 1
So 1150617-54-1 is a valid CAS Registry Number.
1150617-54-1Relevant articles and documents
HEPARAN SULFATE BIOSYNTHESIS INHIBITORS FOR THE TREATMENT OF DISEASES
-
, (2016/05/02)
Described herein are compounds of Formula I, methods of making such compounds, pharmaceutical compositions and medicaments containing such compounds, and methods of using such compounds to treat or prevent diseases or conditions in need of inhibition of heparan sulfate biosynthesis.
N1/N2-Lactam Acetyl-CoA carboxylase inhibitors
-
, (2012/05/07)
The invention provides a compound of Formula (I) or a pharmaceutically acceptable salt thereof; wherein G is R1, R2 and R3 are as described herein; pharmaceutical compositions thereof; and the use thereof in treating diseases, conditions or disorders modulated by the inhibition of an acetyl-CoA carboxylase enzyme(s) in an animal
N2-PYRAZOLOSPIROKETONE ACETYL-COA CARBOXYLASE INHIBITORS
-
, (2011/06/16)
The invention provides a compound of Formula (I) or a pharmaceutically acceptable salt of said compound, wherein R1, R2, R3 and R4 are as described herein; pharmaceutical compositions thereof; and the use thereof in treating diseases, conditions or disorders modulated by the inhibition of an acetyl- CoA carboxylase enzyme(s) in an animal.
